Sentence examples for mammographic density changes from inspiring English sources

Mammographic density changes throughout life and reacts to hormone exposure.

None of the genetic variants predicted mammographic density changes in women using estrogen therapy.

Mammographic density changes over lifetime and generally declines with age [ 3].

The question of whether CYP2D6 could be used as a risk or prognostic marker for mammographic density changes in response to tamoxifen treatment will require larger prospective studies.

In contrast, studies capturing variation in mammographic density through continuous measures that are based on computer threshold programs require smaller changes to reflect mammographic density change.

Both the AKR1C4 and the CYP1B1 polymorphisms predicted mammographic density change in the combined estrogen and progestin therapy group (P < 0.05).

In this study, we explored the association between CYP2D6 metabolizer phenotype and mammographic density change, using breast cancer cases from a population-based breast cancer case control study conducted in Sweden between 1993 and 1995 [ 8- 10].

A recent study showed that the magnitude of the association of exogenous or endogenous hormone exposure and mammographic density change is related to future risk of breast cancer [ 9].

An independent study in an Asian population also showed that mammographic density change during short-term use of adjuvant endocrine therapy was also found to be a significant predictor of long-term recurrence in women with ER-positive breast cancer [ 3].

In an ancillary retrospective study of SMART-1 (n = 507), mean mammographic breast density changes at 2 years with CE 0.45 mg/BZA 20 mg (-0.39%) were similar to those with PBO (-0.42%) and RLX 60 mg (-0.23%) [ 100].

An alternative explanation is therefore that changes in mammographic density primarily reflect stromal changes and that these changes influence breast cancer risk [ 32].